Adams J - Search Results

1

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.

Koup RA, Merluzzi VJ, Hargrave KD, Adams J, Grozinger K, Eckner RJ, Sullivan JL. Koup RA, et al. Among authors: adams j. J Infect Dis. 1991 May;163(5):966-70. doi: 10.1093/infdis/163.5.966. J Infect Dis. 1991. PMID: 1708400

2

Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.

Merluzzi VJ, Hargrave KD, Labadia M, Grozinger K, Skoog M, Wu JC, Shih CK, Eckner K, Hattox S, Adams J, et al. Merluzzi VJ, et al. Among authors: adams j. Science. 1990 Dec 7;250(4986):1411-3. doi: 10.1126/science.1701568. Science. 1990. PMID: 1701568

3

Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapine.

Kelly TA, Proudfoot JR, McNeil DW, Patel UR, David E, Hargrave KD, Grob PM, Cardozo M, Agarwal A, Adams J. Kelly TA, et al. Among authors: adams j. J Med Chem. 1995 Nov 24;38(24):4839-47. doi: 10.1021/jm00024a011. J Med Chem. 1995. PMID: 7490733

4

Crystal structure of nevirapine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, and computational alignment with a structurally diverse inhibitor.

Mui PW, Jacober SP, Hargrave KD, Adams J. Mui PW, et al. Among authors: adams j. J Med Chem. 1992 Jan;35(1):201-2. doi: 10.1021/jm00079a029. J Med Chem. 1992. PMID: 1370694 No abstract available.

5

Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.

Cohen KA, Hopkins J, Ingraham RH, Pargellis C, Wu JC, Palladino DE, Kinkade P, Warren TC, Rogers S, Adams J, et al. Cohen KA, et al. Among authors: adams j. J Biol Chem. 1991 Aug 5;266(22):14670-4. J Biol Chem. 1991. PMID: 1713587 Free article.

6

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.

Wu JC, Warren TC, Adams J, Proudfoot J, Skiles J, Raghavan P, Perry C, Potocki I, Farina PR, Grob PM. Wu JC, et al. Among authors: adams j. Biochemistry. 1991 Feb 26;30(8):2022-6. doi: 10.1021/bi00222a003. Biochemistry. 1991. PMID: 1705436

7

26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer.

Shah SA, Potter MW, McDade TP, Ricciardi R, Perugini RA, Elliott PJ, Adams J, Callery MP. Shah SA, et al. Among authors: adams j. J Cell Biochem. 2001 Apr 2-27;82(1):110-22. doi: 10.1002/jcb.1150. J Cell Biochem. 2001. PMID: 11400168

8

Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes.

Klunder JM, Hoermann M, Cywin CL, David E, Brickwood JR, Schwartz R, Barringer KJ, Pauletti D, Shih CK, Erickson DA, Sorge CL, Joseph DP, Hattox SE, Adams J, Grob PM. Klunder JM, et al. Among authors: adams j. J Med Chem. 1998 Jul 30;41(16):2960-71. doi: 10.1021/jm9707028. J Med Chem. 1998. PMID: 9685235

9

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ. Adams J, et al. Cancer Res. 1999 Jun 1;59(11):2615-22. Cancer Res. 1999. PMID: 10363983

10

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC. Hideshima T, et al. Among authors: adams j. Cancer Res. 2001 Apr 1;61(7):3071-6. Cancer Res. 2001. PMID: 11306489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,026 results

Search Page

Filters